Last update 06 Jun 2026

Hefei Kangnuo Biopharmaceutical Co., Ltd.

Subsidiary Company|2017|Anhui Sheng, China|
www.knb-pharma.com

Overview

Tags

Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Hemic and Lymphatic Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1

Related

1
Drugs associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
Coenzyme I
Target-
Mechanism-
Active Org.
Kaifeng Kangnuo Pharmaceutical Co. Ltd.Kaifeng Kangnuo Pharmaceutical Co. Ltd. [+2]
Originator Org.
Kaifeng Kangnuo Pharmaceutical Co. Ltd.Kaifeng Kangnuo Pharmaceutical Co. Ltd.
Active Indication
Coronary Artery Disease [+6]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date01 Jul 2011
6
Clinical Trials associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
ChiCTR2600125759
/ Not yet recruitingPhase 2IIT
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of Different Doses of Injectable Coenzyme I (NAD+) in the Treatment of Ovarian Function Decline
ChiCTR2500105041
/ Not yet recruitingPhase 2IIT
A randomized, double-blind, placebo-controlled, multicenter, dose-finding phase II clinical study of the efficacy and safety of injectable coenzyme I in patients with heart failure after acute ST-elevation myocardial infarction
CTR20231677
/ CompletedPhase 1
评价注射用辅酶I在健康受试者中单次、多次剂量递增的安全性、耐受性和药代动力学的随机、双盲、安慰剂对照的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase I clinical study evaluating the safety, tolerability, and pharmacokinetics of injectable coenzyme I in healthy subjects with single-dose, multiple-dose escalation regimens.
100 Clinical Results associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Hefei Kangnuo Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Coenzyme I
ST Elevation Myocardial Infarction
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free